Utah Medical Products Price to Book Ratio 2010-2024 | UTMD
Historical price to book ratio values for Utah Medical Products (UTMD) over the last 10 years. The current price to book ratio for Utah Medical Products as of May 07, 2025 is 1.55.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Utah Medical Products Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-05-07 | 53.93 | 1.53 | |
| 2024-12-31 | 61.14 | $35.21 | 1.74 |
| 2024-09-30 | 66.23 | $36.09 | 1.83 |
| 2024-06-30 | 65.84 | $35.45 | 1.86 |
| 2024-03-31 | 69.76 | $35.60 | 1.96 |
| 2023-12-31 | 82.27 | $35.35 | 2.33 |
| 2023-09-30 | 83.72 | $34.09 | 2.46 |
| 2023-06-30 | 90.41 | $33.55 | 2.69 |
| 2023-03-31 | 91.65 | $32.53 | 2.82 |
| 2022-12-31 | 96.91 | $31.49 | 3.08 |
| 2022-09-30 | 81.98 | $29.84 | 2.75 |
| 2022-06-30 | 82.28 | $29.65 | 2.78 |
| 2022-03-31 | 85.77 | $29.87 | 2.87 |
| 2021-12-31 | 95.13 | $29.31 | 3.25 |
| 2021-09-30 | 86.73 | $30.14 | 2.88 |
| 2021-06-30 | 79.20 | $29.45 | 2.69 |
| 2021-03-31 | 80.37 | $28.77 | 2.79 |
| 2020-12-31 | 78.00 | $28.22 | 2.76 |
| 2020-09-30 | 73.67 | $27.04 | 2.72 |
| 2020-06-30 | 81.45 | $26.16 | 3.11 |
| 2020-03-31 | 86.19 | $25.92 | 3.33 |
| 2019-12-31 | 98.56 | $27.16 | 3.63 |
| 2019-09-30 | 87.31 | $25.53 | 3.42 |
| 2019-06-30 | 86.94 | $25.25 | 3.44 |
| 2019-03-31 | 79.90 | $24.76 | 3.23 |
| 2018-12-31 | 74.98 | $23.92 | 3.13 |
| 2018-09-30 | 84.75 | $23.79 | 3.56 |
| 2018-06-30 | 98.82 | $22.34 | 4.42 |
| 2018-03-31 | 88.45 | $22.18 | 3.99 |
| 2017-12-31 | 72.62 | $20.99 | 3.46 |
| 2017-09-30 | 65.40 | $21.83 | 3.00 |
| 2017-06-30 | 64.15 | $20.78 | 3.09 |
| 2017-03-31 | 54.99 | $19.53 | 2.82 |
| 2016-12-31 | 63.93 | $18.65 | 3.43 |
| 2016-09-30 | 52.35 | $19.32 | 2.71 |
| 2016-06-30 | 54.92 | $18.90 | 2.91 |
| 2016-03-31 | 54.30 | $19.07 | 2.85 |
| 2015-12-31 | 50.61 | $18.57 | 2.73 |
| 2015-09-30 | 46.36 | $18.23 | 2.54 |
| 2015-06-30 | 51.07 | $18.15 | 2.81 |
| 2015-03-31 | 51.03 | $17.01 | 3.00 |
| 2014-12-31 | 50.98 | $17.22 | 2.96 |
| 2014-09-30 | 41.21 | $17.16 | 2.40 |
| 2014-06-30 | 43.26 | $17.36 | 2.49 |
| 2014-03-31 | 48.40 | $16.76 | 2.89 |
| 2013-12-31 | 47.62 | $16.19 | 2.94 |
| 2013-09-30 | 49.27 | $15.27 | 3.23 |
| 2013-06-30 | 44.79 | $14.12 | 3.17 |
| 2013-03-31 | 40.02 | $13.63 | 2.94 |
| 2012-12-31 | 29.43 | $13.77 | 2.14 |
| 2012-09-30 | 27.56 | $13.19 | 2.09 |
| 2012-06-30 | 26.99 | $12.36 | 2.18 |
| 2012-03-31 | 24.86 | $12.14 | 2.05 |
| 2011-12-31 | 21.41 | $11.20 | 1.91 |
| 2011-09-30 | 20.82 | $11.10 | 1.88 |
| 2011-06-30 | 20.45 | $11.00 | 1.86 |
| 2011-03-31 | 22.31 | $10.60 | 2.10 |
| 2010-12-31 | 20.57 | $10.44 | 1.97 |
| 2010-09-30 | 21.64 | $11.00 | 1.97 |
| 2010-06-30 | 18.28 | $10.75 | 1.70 |
| 2010-03-31 | 20.45 | $10.69 | 1.91 |
| 2009-12-31 | 21.15 | $10.52 | 2.01 |
| 2009-09-30 | 20.98 | $10.33 | 2.03 |
| 2009-06-30 | 18.95 | $10.04 | 1.89 |
| 2009-03-31 | 16.17 | $9.81 | 1.65 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.176B | $0.041B |
| Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.503B | 27.84 |
| Boston Scientific (BSX) | United States | $154.040B | 38.56 |
| Stryker (SYK) | United States | $144.095B | 30.13 |
| EssilorLuxottica (ESLOY) | France | $132.622B | 0.00 |
| Medtronic (MDT) | Ireland | $105.579B | 15.42 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.866B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.124B | 27.36 |
| ResMed (RMD) | United States | $35.477B | 26.65 |
| GE HealthCare Technologies (GEHC) | United States | $30.720B | 14.59 |
| Agilent Technologies (A) | United States | $30.004B | 19.82 |
| Terumo (TRUMY) | Japan | $29.197B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.643B | 16.28 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.255B | 11.72 |
| Insulet (PODD) | United States | $18.215B | 77.74 |
| Baxter (BAX) | United States | $15.352B | 11.47 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.456B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.970B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.179B | 17.65 |
| Bio-Rad Laboratories (BIO) | United States | $6.487B | 21.93 |
| Prestige Consumer Healthcare (PBH) | United States | $4.014B | 19.16 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.368B | 9.64 |
| ICU Medical (ICUI) | United States | $3.306B | 28.16 |
| Haemonetics (HAE) | United States | $3.194B | 15.03 |
| Envista Holdings (NVST) | United States | $2.778B | 23.08 |
| GN Store Nord (GNNDY) | Denmark | $2.069B | 17.14 |
| LeMaitre Vascular (LMAT) | United States | $1.855B | 41.46 |
| QuidelOrtho (QDEL) | United States | $1.750B | 14.65 |
| AtriCure (ATRC) | United States | $1.478B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.281B | 20.17 |
| AdaptHealth (AHCO) | United States | $1.194B | 12.12 |
| Neogen (NEOG) | United States | $1.192B | 15.25 |
| Kestra Medical Technologies (KMTS) | United States | $1.139B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.043B | 0.00 |
| InMode (INMD) | Israel | $0.995B | 9.11 |
| Phibro Animal Health (PAHC) | United States | $0.771B | 11.83 |
| Evolus (EOLS) | United States | $0.749B | 0.00 |
| Owens & Minor (OMI) | United States | $0.596B | 5.07 |
| Curaleaf Holdings (CURLF) | Canada | $0.579B | 0.00 |
| CeriBell (CBLL) | United States | $0.568B | 0.00 |
| Valneva SE (VALN) | France | $0.542B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.518B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.424B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.420B | 0.00 |
| Surmodics (SRDX) | United States | $0.391B | 0.00 |
| Omeros (OMER) | United States | $0.370B | 0.00 |
| SNDL (SNDL) | Canada | $0.344B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.340B | 14.75 |
| Capricor Therapeutics (CAPR) | United States | $0.333B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.302B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.292B | 26.43 |
| Sanara MedTech (SMTI) | United States | $0.283B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.262B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.259B | 46.10 |
| ZimVie (ZIMV) | United States | $0.245B | 14.65 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.235B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.217B | 0.00 |
| Quanterix (QTRX) | United States | $0.208B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Biote (BTMD) | United States | $0.184B | 4.21 |
| TriSalus Life Sciences (TLSI) | United States | $0.166B | 0.00 |
| Brainsway (BWAY) | Israel | $0.162B | 50.65 |
| Organigram Global (OGI) | Canada | $0.147B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.146B | 17.99 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.117B | 0.00 |
| Exagen (XGN) | United States | $0.116B | 0.00 |
| Agape ATP (ATPC) | $0.103B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.091B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.086B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.58 |
| Veru (VERU) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Zynex (ZYXI) | United States | $0.061B | 0.00 |
| United Health Products (UEEC) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.046B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Apyx Medical (APYX) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 55.50 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 11.14 |
| Nephros (NEPH) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |